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Background: Calciphylaxis (calcific uremic arteriolopathy) is rare and its pathogenesis is not fully understood.
Indeed, Calciphylaxis presents a challenge through the course of its management which involve different
specialities but unfortunately this disease so far has a poor prognosis. We herein present, in this case report, a
multidisciplinary approach involving plastic surgeons with special regards to reconstructive approach after
debridement procedures.
Case presentation: We present a 21 years old male with a BMI of 38,2, who was transferred to our department
from another hospital. Calciphylaxis has been diagnosed after receiving anticoagulation with phenprocoumon after
a single event of pulmonary embolism. The INR on admission was 1,79. He had necrotic spots on both sides of the
abdominal wall and on both thighs medially. During this time he underwent several reconstructive procedures in
our department.
Conclusion: It can be suggested that this agonizing disease needs indeed a multidisciplinary approach involving
Nephrologists, Dermatologists, Intensive Care Physicians and Plastic Surgeons, taking into consideration that surgical
correction can achieve further improvement in a specialized centre. Notwithstanding, further cohort studies should
be approached clinically to insight the light on this disease with special regard to the prognosis after this approach.
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Calciphylaxis (calcific uremic arteriolopathy) is a rare and
poorly understood disease which demonstrates a challenge
for different specialities. Media calcifications of arterioles
and fat tissue are distinctive and primarily affect the skin
but in some cases involvement of nerve sheaths, visceral
organs and muscles have been described. Even if diag-
nosed in an early phase, the chances of success in healing
are very low and the mortality is exceptionally high [1].
It is characterized by extremely painful, partly necrotic
skin ulcerations, which can be found almost on any part
of the body. Hallmark of this disease is a fortified calcifi-
cation of the arterioles mainly in the subcutaneous tissue
and sometimes even calcification of peripheral nerve
sheaths and fat cell bodies can be found [1]. The primary
clinical picture is multifaceted and can delay diagnosis.* Correspondence: s.tsolakidis@me.com
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vasculitis, cholesterol emboli and diabetic ulcers.
Calciphylaxis can be staged into two phases. Phase one
is characterized by pruritus, cutaneous laminar erythe-
mas, which is unspecific and therefore can easily be mis-
interpreted in the first place. Phase two shows painful
ulceration and necrosis [2]. Preferably affected areas are
the lower extremities. There are some cases described
where also the abdomen and visceral organs were
affected. The mortality in phase one is about 30%, but
the mortality in phase two is extended up to 80% [3].
These typical ulcerations and necrosis were predomin-
antly presented on the abdomen and both thighs of the
patient we treated.
This rare disease was first described by Bryant and
White in 1898, where a condition of calcifications and
cutaneous necrosis was circumscribed [4]. Selye et al.
were the first, who highlightened the pathophysiology of
calciphylaxis, labelled the disease in 1962 and charac-
terised it as a systemic hypersensitivity reaction. In ani-
mal experiments, Selye et al. could show an induction ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Shows the patient's wounds on both thighs and the
abdominal wall on admission in our department.
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sensitizing agents, like Dihydrotachysterol, Vitamin D2,
D3 and parathyroid hormone followed by exposure to a
challenger, as there are for example metallic salts (iron,
aluminium)or trauma [5-7]. Ketteler et al. referred the
condition can lead to an imbalance of two calcification
inhibiting proteins; Matrix-Gla and Fetuin A, which are
Vitamin K dependant [8]. In animal experiments it could
be shown that an essential lack of these proteins can
lead to calcification of arteries and even rupturing of the
aorta [9,10].
Even the risk factors seem to be controversial. Predis-
posing factors are an acute or chronic renal failure,
obesity, diabetes, hyperparathyroidism, female Cauca-
sians and an elevated calcium phosphorus product.
Further presumably risk factors are phenprocoumon,
vitamin K deficiency (phytonadione), lack of fetuin A
protein, malignancy, alcoholic liver disease, connective
tissue disease, protein C and S deficiency [11]. Interest-
ingly the majority of these patients had normal serum
calcium, normal serum phosphorus, normal calcium
phosphorus product, normal serum parathyroid hor-
mone levels and normal serum creatinine levels. The
mortality rate in this study was 52% with sepsis being
the leading cause [12].
Although the risk remains to cause another compli-
cated ulcer, a histological sample excision also including
subcutaneous tissue is mandatory. The sample has to be
stained with alizarin red or silver-nitrate to differentiate
Calciphylaxis from different diseases [11].
Fine et al. suggested bone scintigraphy as one of the
first steps to substantiate the diagnosis. In their study,
only one of the investigated cases had negative bone
scan [13] .The mortality in phase one was 33%. After de-
velopment of ulcers the mortality reached 80% [13,14].
In this case report, we highlight a multidisciplinary
treatment of a patient, suffering from Calciphylaxis,
which after 10 months led to a successful result.
Case presentation
We report on an obese 21 years old male with a Body
Mass Index (BMI) of 38,2, who presented to our depart-
ment with Calciphylaxis after phenprocoumon intake in
consequence of pulmonary embolism. The target partial
thrombin time (pTT) was between 50-60s. In addition
the patient lost overtime 100 kg body mass after getting
a gastric banding in 2007. Comorbidities were a dilative
cardiomyopathy, insulin dependant diabetes, obesity,
allergic asthma, hypothyreoidism and lack of anithrom-
bine factor III (AT3).
Calciphylaxis was already diagnosed histologically
in the former hospital, where he was treated with
Natriumthiosulphate intravenously for about 9 weeks.
Initial symptoms were tender and painful lesions withdefined edges in the upper and lower thighs and the ab-
domen, where some showed signs of necrosis. Further
histological examinations showed typical signs of micro-
thrombosis and calcification of the arterioles subcutane-
ously and substantiated the diagnosis of calciphylaxis.
The patient needed high doses of opiates over the
whole duration of inpatient treatment. Unfortunately the
initial calcifications became necrotic and possible surgi-
cal options were evaluated.
A combination of Natriumthiosulphate was adminis-
tered intravenously, which is a common therapy for
calciphylaxis and a specific surgical approach to this
complex disease was initiated when the patient arrived
at our department. The patient had necrosis on the
abdomen and both thighs as well as partially superin-
fected wounds with oxacillin resistant staphylococcus
aureus (Figure 1). A bone scintigraphy revealed no
increased activity of calcium carbonate in thighs or the
abdominal area.
After the patient consented to a surgical treatment we
started our surgical approach with extensive debride-
ment of the affected areas on the abdominal wall and
both thighs (Figure 2). A consecutive VAC therapy for
the lesions on the thighs was mandatory to establish a
clean environment. At this level, attempt to close the
Figure 2 Shows exemplary the wounds on the thigh after
initial debridements in our department.
Figure 3 Shows the clinical setting after successful skin
grafting procedures. The wounds were closed.
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unsuccessful.
A main problem to deal with was not only a perman-
ent level of extensive pain which was encountered
through our pain specialists in concordance with the
WHO – pain schedule with opiates but also the recur-
rent wound infections with complicated germs, which
were treated with different antibiotic patterns. Over time
the Calciphylaxis therapy was adjusted and complemented
with Pamidronat, a biphosphonate agent to reduce decom-
position of osseous structures and Renagel (Sevelamer), a
phosphate binder.
Initial skin grafts did not show satisfactory results in
the beginning of the surgical treatment; hence another
attempt with skin grafts in buried chips technique was
preceded 6 months after admission.
From the plastic surgical point of view, the complexity
of the wounds demanded a combination of consecutive
debridements, jet lavages, repetitive VAC therapies and
Buried chip skin grafting (both thighs and abdomen). In
addition dressings were changed with an ointment pad
and silver coating dressing (Atrauman Ag, Paul Hartmann
Ges.m.b.H, Wiener Neudorf – Austria) as well as antisep-
tic solution (Polyhexanid, Lohmann & Rauscher GmbH &
Co. KG, Neuwied – Germany) on a daily basis. The pa-
tient could be sufficiently mobilized and had no further
signs of infection. Daily sea salt baths and physiotherapy
sessions improved the patient’s status until he was able to
walk alone on the ward.
Finally, pain medication could be reduced drastically
and sedoanalgesia was not further necessary for dressing
changes. The laboratory on discharge showed a single
slight elevated phosphate of 1.88 (0.84-1.48 mmol/l). Cal-
cium was in normal range (2.10-2.60 mmol/l). Creatinine
was 1.5 (0.7-1.2). We could successfully discharge thepatient into rehabilitation, where his status was further
improved by mobilization, physiotherapy and lymphatic
drainage massages.
Conclusion
Calciphylaxis still remain a challenge and need further
investigation to understand this disease although differ-
ent causes and numerous therapeutic strategies have
been described. A further challenge in the clinical setting
is that the therapy for Calciphylaxis is not clearly
defined. Independently of the causing agent (factor), the
present therapeutic strategy enfolds pain control, sur-
gery, calcium binding agents, phosphorus reducer, corti-
sone, and antibiotic therapy.
Regarding our patient, we treated him with a combin-
ation of surgical approach with intravenous application
of binding agents which have led to a successful out-
come. However, it should be stated that local flap techni-
ques showed no benefit but merely buried skin grafting
was finally crowned with success. Therefore an interdis-
ciplinary approach to this disease via supporting drug
therapy and surgical measures may be a promising
way to treat patients suffering from Calciphylaxis. The
patient was then discharged into rehabilitation centre
without further wound problems in his soft tissues
and until recently showed no signs of a relapse of Calci-
phylaxis (Figure 3 ).
Notwithstanding, despite the fact that this surgical
approach may lead to a satisfactory result in our patient
further studies with a larger patient cohort will be needed
to determine its efficiency for these patients.
Consent
Written informed consent was obtained from the patient
for publication of this case presentation and any accom-
panying images.
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